Posted by Hans Peng ⎜ Aug 2, 2018 ⎜ Industry
Since China was the highlighted country of 2018 SNMMI in Philadelphia, several CSNM board members presented a brief report of 2018 SNMMI to the audience. One interesting fact needs attention is that Lu-177 is the most discussed topic this year not only because Lu-177 is highly in demand during SNMMI, but also more and more professors and doctors in China have realized how important and effective Lu-177 is when it is used to diagnose and treat prostate cancer.
During this CSNM Meeting, professors and doctors have expressed their strong interest and hope that Lu-177 can be used more in the diagnose and treatment of prostate cancer and they believe that domestically produced Lu-177 can lower the cost of treatment dramatically for normal patients.
Tags: China CSNM Lu-177 Radiochemicals SNMMI